Geron

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. 

CEO
Dawn Carter Bir
CEODawn Carter Bir
Employees
229
Employees229
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
1990
Founded1990
Employees
229
Employees229

GERN Key Statistics

Market cap
958.56M
Market cap958.56M
Price-Earnings ratio
-7.16
Price-Earnings ratio-7.16
Dividend yield
Dividend yield
Average volume
10.36M
Average volume10.36M
High today
$1.57
High today$1.57
Low today
$1.50
Low today$1.50
Open price
$1.53
Open price$1.53
Volume
7.48M
Volume7.48M
52 Week high
$5.06
52 Week high$5.06
52 Week low
$1.17
52 Week low$1.17

GERN News

Simply Wall St 1d
Geron Corporation's Shares Climb 30% But Its Business Is Yet to Catch Up

Geron Corporation ( ) shareholders are no doubt pleased to see that the share price has bounced 30% in the last month, although it is still struggling to make u...

Geron Corporation's Shares Climb 30% But Its Business Is Yet to Catch Up
Simply Wall St 4d
Favourable Signals For Geron: Numerous Insiders Acquired Stock

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Geron Corporation ( ),...

Favourable Signals For Geron: Numerous Insiders Acquired Stock

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.